Global Left Ventricular Assist Device (LVAD) Market Growth 2022-2028

SKU ID :LPI-19843602 | Published Date: 05-Jan-2022 | No. of pages: 103
As the global economy mends, the 2021 growth of Left Ventricular Assist Device (LVAD) will have significant change from previous year. According to our (LP Information) latest study, the global Left Ventricular Assist Device (LVAD) market size is USD million in 2022 from USD 2389.1 million in 2021, with a change of % between 2021 and 2022. The global Left Ventricular Assist Device (LVAD) market size will reach USD 6658.1 million in 2028, growing at a CAGR of 15.8% over the analysis period.
The United States Left Ventricular Assist Device (LVAD) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Left Ventricular Assist Device (LVAD) market, reaching US$ million by the year 2028. As for the Europe Left Ventricular Assist Device (LVAD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Left Ventricular Assist Device (LVAD) players cover AbioMed, Abbott (Thoratec), Medtronic (HeartWare), and Berlin Heart, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Left Ventricular Assist Device (LVAD) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
BTT Therapy
Destination Therapy (DT)
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbioMed
Abbott (Thoratec)
Medtronic (HeartWare)
Berlin Heart
Jarvik Heart
Sun Medical Technology Research
ReliantHeart

Market Segment by Product Type


BTT Therapy
Destination Therapy (DT)
  • PRICE
  • $3660
    $7320
    $5490
    Buy Now

Our Clients